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Abstract
Transient global cerebral ischemia induces profound changes in the transcriptome of brain cells, which is partially
associated with the induction or repression of genes that influence the ischemic response. However, the mechanisms
responsible for the selective vulnerability of hippocampal neurons to global ischemia remain to be clarified. To identify
molecular changes elicited by ischemic insults, we subjected hippocampal primary cultures to oxygen-glucose deprivation
(OGD), an in vitro model for global ischemia that resulted in delayed neuronal death with an excitotoxic component. To
investigate changes in the transcriptome of hippocampal neurons submitted to OGD, total RNA was extracted at early (7 h)
and delayed (24 h) time points after OGD and used in a whole-genome RNA microarray. We observed that at 7 h after OGD
there was a general repression of genes, whereas at 24 h there was a general induction of gene expression. Genes related
with functions such as transcription and RNA biosynthesis were highly regulated at both periods of incubation after OGD,
confirming that the response to ischemia is a dynamic and coordinated process. Our analysis showed that genes for
synaptic proteins, such as those encoding for PICK1, GRIP1, TARPc3, calsyntenin-2/3, SAPAP2 and SNAP-25, were down-
regulated after OGD. Additionally, OGD decreased the mRNA and protein expression levels of the GluA1 AMPA receptor
subunit as well as the GluN2A and GluN2B subunits of NMDA receptors, but increased the mRNA expression of the GluN3A
subunit, thus altering the composition of ionotropic glutamate receptors in hippocampal neurons. Together, our results
present the expression profile elicited by in vitro ischemia in hippocampal neurons, and indicate that OGD activates a
transcriptional program leading to down-regulation in the expression of genes coding for synaptic proteins, suggesting that
the synaptic proteome may change after ischemia.
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Introduction
Global cerebral ischemia is a pathological condition in which
brain tissue is subjected to reduced levels of oxygen and glucose
due to impairment in blood supply to the entire brain, causing
biochemical modifications in the normal functioning of neurons
that can lead to injury in specific neuronal subpopulations. One of
the main features of transient global cerebral ischemia is the
delayed death of the pyramidal neurons of the CA1 region of the
hippocampus, which occurs hours to days after the insult. This
time-window between the end of the transient ischemic insult and
the first signs of neuronal demise is believed to be associated with
the activation of competing programs of gene expression, in which
some will facilitate cell survival, whereas others will contribute to
neuronal death [1].
A great effort has been put into identifying genes that
participate in the response of hippocampal cells to global cerebral
ischemia in vivo [2–4]. However, while it is accepted that several
cellular functions are compromised, our understanding of how this
correlates with the selective and delayed death of hippocampal
neurons is still unclear. This analysis requires investigations at the
molecular level, more easily performed using in vitro models. In the
present study we used microarray technology to identify genes
whose expression is significantly altered in hippocampal neuronal
cultures submitted to oxygen and glucose deprivation (OGD), an
established in vitro model for cerebral global ischemia [5]. To the
best of our knowledge no large scale study was developed so far
using an OGD insult as a tool to study ischemia-induced changes
in the transcriptome of hippocampal neurons at different periods
of recovery. In accordance to what has been previously observed
in models of global and focal ischemia [2–4,6–9], OGD induced
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changes in the expression levels of genes related with a variety of
functions within neurons, such as the synapse. Failure in synaptic
activity is one of the earliest events in cerebral ischemia, due to the
energetic imbalance that occurs during an ischemic insult and that
leads to neuronal depolarization and impaired neurotransmission
[10]. Moreover, there are biochemical alterations that occur in
neurons submitted to ischemic insults, which include changes in
the expression levels and the molecular composition of proteins
related with synaptic transmission, such as the ionotropic
glutamate receptors of the a-amino-3-hydroxy-5-methyl-4-isoxa-
zolepropionic acid (AMPAR) and the N-methyl-D-aspartate
(NMDAR) types, among other proteins [11–14] that can be
implicated in the mechanisms promoting either cell death or cell
survival.
In particular, we observed that OGD up-regulates REST
expression, triggers a transcriptional program that down-regulates
synaptic protein-encoding genes and induces changes in the
subunit composition of the AMPAR and the NMDAR subtypes.
The extent to which the post-ischemic alterations identified in this
work influence the fate of neuronal cells exposed to ischemia can
now be addressed, and may result in the identification of attractive
therapeutic targets for the treatment of cerebral ischemia.
Methods
Primary hippocampal neuronal cultures
Primary cultures of rat hippocampal neurons were prepared
from the hippocampi of E18-E19 Wistar rat embryos, after
treatment with trypsin (0.06%, 15 min, 37uC; Gibco Invitrogen,
Paisley, UK) in Ca2+- and Mg2+-free Hank’s balanced salt solution
(HBSS; in mM: 5.36 KCl, 0.44 KH2PO4, 137 NaCl, 4.16
NaHCO3, 0.34 Na2HPO 4.2H2O, 5 glucose, 1 sodium pyruvate,
10 HEPES and 0.001% phenol red). The hippocampi were then
washed with HBSS containing 10% fetal bovine serum (Gibco
Invitrogen), to stop trypsin activity, and transferred to Neurobasal
medium (Gibco, Life Technologies, Paisley, UK), supplemented
with SM1 neuronal supplement (1:50 dilution; Stem Cell
Technologies, Grenoble, France), 25 mM glutamate, 0.5 mM
glutamine and 0.12 mg/ml gentamycin (Sigma-Aldrich, St Louis,
MO). The cells were dissociated in this solution and were then
plated in 6-well microplates (MW6) (for Western blot and real-time
PCR experiments) or 24-well microplates (MW24) (for cell death
assays), previously coated with poly-D-lysine (0.1 mg/mL, Sigma-
Aldrich), or on poly-D-lysine coated glass coverslips, at a density of
85.06103 cells/cm2. The cultures were maintained in a humidified
incubator with 5% CO2/95% air, at 37uC, for 14–15 days.
According to what has been previously observed in our lab [15],
we estimate that hippocampal cultures contain,10% of glial cells.
All animal procedures were reviewed and approved by DGAV,
Portugal.
Oxygen-Glucose Deprivation (OGD)
For the OGD insult, hippocampal cultures were incubated in a
glucose–free saline buffer (in mM: 10 HEPES, 116 NaCl, 5.4 KCl,
0.8 MgSO4, 1 NaH2PO4, 1.8 CaCl2, 25 NaHCO3, 25 sucrose,
pH 7.3) in an anaerobic chamber (Thermo Forma 1029, Thermo
Fisher Scientific, Waltham, MA), at 37 uC, for the indicated
periods of time. Control neurons were placed in a similar saline
buffer with 25 mM glucose instead of sucrose and kept in an air/
CO2 incubator, at 37uC, for the same period of time. After the
stimulation periods, the saline buffers were replaced by the
conditioned medium and the cultures returned to the air/CO2
incubator, where they were left to recover for the indicated times.
In studies performed in the presence of the NMDA receptor
antagonist MK-801 (10 mM), the AMPA receptor antagonist
GYKI 52466 (50 mM) and the selective Ca2+-permeable AMPARs
(CP-AMPARs) antagonist Naspm (50 mM), a pre-incubation of 15
minutes was done and the antagonists were present during both
the insult and the post-ischemic period. MK-801, GYKI 52466
and Naspm were purchased from Tocris Bioscience (Bristol, UK).
In the studies performed in the presence of the calpain inhibitor
MDL 28170 (50 mM, Calbiochem, Darmstadt, Germany), a pre-
incubation of 30 minutes was done and the inhibitor was present
during both the insult and the post-ischemic period.
Analysis of the nuclear morphology
For analysis of the nuclear morphology, neurons were fixed
24 h after OGD at room temperature in 4% sucrose/4%
paraformaldehyde in phosphate-buffered saline (PBS), washed
with PBS and incubated with the fluorescent dye Hoechst 33342
(1 mg/ml, Molecular Probes Europe) for 10 min. The coverslips
were mounted on glass slides with Dako mounting medium
(Thermo Scientific) and examined with a Zeiss Axiovert 200
fluorescence microscope (406 objective). The cell-permeable
DNA stain Hoechst 33342 presents blue fluorescence. Viable cells
display a normal nuclear size and a diffuse blue fluorescence,
whereas damaged cells display bright blue pyknotic nuclei with
condensed or fragmented chromatin [16]. The experiments were
performed in duplicate and approximately 400 cells were counted
per coverslip in 6–10 distinct randomly selected optical fields. Cell
death is expressed as the percentage of dead cells relatively to the
total number of scored cells.
LDH release assay
For the assessment of lactate dehydrogenase (LDH) release, the
culture conditioned medium was collected after the indicated times
of incubation after exposure to OGD or control conditions. The
LDH activity was assayed using a commercial kit (CytoTox 96
Non-Radioactive Cytotoxicity Assay, Promega, Madison, WI),
and determined as indicated in the manufacturer’s protocol. The
percentage of LDH release was determined as the ratio between
LDH activity in the extracellular medium and total LDH activity,
obtained after complete cell lysis with Triton X-100. The
percentage of cell death was calculated relatively to cells treated
with lysis buffer, which were considered as 100%. All experiments
were carried out in duplicate or triplicate, for each independent
experiment.
Total RNA isolation, RNA Quality and RNA Concentration
Seven and 24 hours after the OGD challenge, total RNA was
extracted from cultured hippocampal neurons with TriZol reagent
(Gibco Invitrogen), following the manufacturer’s specifications.
Briefly, 1 ml of TRIzol was added to each well of a 6-well plate
and the content of each experimental condition (two wells) was
collected. Chloroform was then added for phase separation and
the RNA precipitated by isopropanol addition. The precipitated
RNA was washed with 75% ethanol, centrifuged, air-dried and
resuspended in 20 ml of RNase-free water (Gibco Invitrogen).
RNA quality and integrity were evaluated using the Experion
automated gel-electrophoresis system (Bio-Rad, Hercules, CA).
RNA concentration was determined spectrophotometrically using
Nanodrop 2000 (Thermo Fisher Scientific, Wilmington, DE). The
samples were stored at 280uC until further use.
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Microarray hybridization
For the microarray analysis, total RNA from rat hippocampal
neuronal cultures subjected to control or OGD conditions was
collected after 7 h and 24 h of post-incubation in culture
conditioned medium. RNA from three independent cultures was
used as biological replicates. Equal amounts of RNA extract
(200 ng) from each replicate were amplified and Cy-3-labeled
using the Low Input Quick Amp Labeling kit (Agilent Technol-
ogies, Santa Clara, CA). Hybridizations were carried out following
Agilent Technologies instructions for One-Color Microarray-
Based Gene Expression Analysis (Agilent Technologies), using
whole-genome Rat GE 4644K v3 Microarrays. Images were
obtained using the Agilent G2565AA microarray scanner and
fluorescence quantization was performed using the Agilent Feature
Extraction 10.5.1.1 software and the GE1_105_Dec08 protocol.
The signal intensity was aligned and normalized between
microarrays by centering the median of the signal distribution
using BRB-ArrayTools v3.8.1. The microarray data was submitted
to GEO database and has been given the accession number
GSE54037.
Microarray data analysis
The TIGR MultiExperiment Viewer (MeV) v4.6 was used for
statistical analysis of the data. Student’s t-test was used to
determine differentially expressed genes, with a p-value cut-off of
0.05. Of these, only genes with a fold change above 2.0 were
considered differentially expressed and included in further
analyses.
For gene ontology analyses, the lists of differentially expressed
genes from all conditions were imported to GoMiner. Ontological
classes were selected manually and, for the production of the pie-
charts, the number of genes for each class were divided by the sum
of the total number of genes in the selected classes, as indicated in
figure captions.
Primer Design
Primers for target genes were designed using the ‘‘Beacon
Designer 7’’ software (Premier Biosoft International), with the
following specifications: (1) GC content about 50%; (2) Annealing
temperature (Ta) between 5565uC; (3) Secondary structures and
primer-dimers were avoided; (4) Primers length between 18–
24 bp; (5) Final product length between 100–200 bp. All primers
used in this work are listed in Table S1.
Real-Time PCR
For cDNA synthesis, 1 mg of total RNA was used with the
iScript cDNA Synthesis Kit (BioRad), according to the manufac-
turers’ instructions. For real-time PCR (qPCR) 20 ml reactions
were prepared with 2 ml of 1:10 diluted cDNA, 10 ml of 2x iQ
SYBR Green Supermix (Bio-Rad) and specific primers at 250 nM.
The fluorescent signal was measured after each elongation step of
the PCR reaction, in the iQ5 Multicolor Real-Time PCR
Detection System (Bio-Rad), and was used to determine the
threshold cycle (Ct), as previously described [17]. Melting curves
were performed in order to detect non-specific amplification
products, a non-template control was included in all assays, and
for each set of primers a standard curve was performed to assess
primer efficiency. Reactions were run in duplicate. For each gene,
average Ct was calculated as the mean of five biological replicates
for each condition. The expression level of each gene was
normalized to the expression level of the gene in the corresponding
control condition. All Ct values were normalized to two internal
control genes, Actb and Gapdh (shown not to change between
control and OGD conditions), using the GenEx software (MultiD
Analyses). Fold change values above 1.0 indicate an up-regulation
relative to the control condition, whereas fold change values below
1 indicate a down-regulation relative to the control condition. All
values are indicated as log-transformed data.
Preparation of total protein extracts
Hippocampal neuronal cultures were washed twice with ice-
cold PBS before addition of ice-cold lysis buffer (in mM: 50
HEPES, 150 NaCl, 2 EGTA, 2 EDTA, 2 Na3VO4, 50 NaF,
pH 7.4, with 1% Triton X-100) supplemented with 1 mM DTT
and a mixture of protease inhibitors: 0.1 mM PMSF and CLAP
(1 mg/ml chymostatin, 1 mg/ml leupeptin, 1 mg/ml antipain, and
1 mg/ml pepstatin (Sigma-Aldrich). Samples were frozen twice at -
80uC, after which the total protein was quantified using the BCA
method (Thermo Scientific). Samples were then denatured with 2x
concentrated denaturing buffer (125 mM Tris, pH 6.8, 100 mM
glycine, 4% SDS, 200 mM DTT, 40% glycerol, 3 mM sodium
orthovanadate, and 0.01% bromophenol blue) at 95uC for 5 min.
Biotinylation assay
Biotinylation assays were performed 24 h after the OGD insult.
Cells were washed twice with PBS containing calcium and
magnesium (PBS/Ca2+/Mg2+; in mM: 137 NaCl, 2.7 KCl, 1.8
KH2PO4, 10 Na2POH4, plus 0.5 MgCl2, 1 CaCl2, pH 7.4),
followed by incubation with 0.25 mg/ml NHS-SS-Biotin (Thermo
Scientific) for 15 min at 4uC under mild shaking. Cells were then
washed twice with PBS/Ca2+/Mg2+ supplemented with glycine
(100 mM) and incubated in this solution for 15 min at 4uC under
mild shaking. For analysis of the surface AMPA receptors
(AMPAR), cells were lysed in the lysis buffer indicated above for
total protein extracts, supplemented with protease inhibitors,
followed by 30 min incubation on ice, and frozen at 280uC. After
thawing, cellular extracts were centrifuged at 18,000 g for 30 min
at 4uC and the pellet was discarded. Fifty mg of each protein
extract was used for the input and 150 mg was used for incubation
with NeutrAvidin beads. For analysis of the surface NMDA
receptors (NMDAR), cells were incubated with lysis buffer (in mM:
50 Tris-HCl, pH 7.4, 5 EGTA, 1 DTT), supplemented with
protease inhibitors, for 30 min at 4uC under mild shaking, after
which samples were collected and briefly sonicated. Cellular
extracts were then incubated with 1% DOC, pH 9.0, for 1 h at
37uC, centrifuged at 18,000 g for 30 min at 4uC and the pellet was
discarded. One hundred mg of each protein extract was used for
the input and 400 mg was used for incubation with NeutrAvidin
beads.
In both cases, NeutrAvidin beads were added in equal amounts
to the supernatant fluid (2.5 ml/10 mg total protein) and incubated
for 2 h at 4uC in an orbital shaker. The beads were washed four
times with the correspondent lysis buffer. The samples were then
eluted with 2x denaturating buffer, boiled at 95uC for 5 min and
centrifuged into a tube collector with a 0.45 mm filter.
Preparation of nuclear protein extracts
Nuclear extracts of hippocampal neurons were prepared 24 h
after the OGD insult. Cells were washed with ice-cold PBS and
solubilized in ice-cold buffer 1 (in mM: 10 HEPES, 10 NaCl, 3
MgCl2, 1 EGTA and 0.1% Triton X-100, pH 7.5) for 30–40 min.
The nuclei were pelleted by centrifugation at 2,400 g for 10 min at
4uC and then resuspended in ice-cold buffer 2 (in mM: 25 HEPES,
300 NaCl, 5 MgCl2, 1 EGTA and 20% glycerol, pH 7.4) for 1 h,
after which they were centrifuged at 12,000 g for 20 min at 4uC.
The supernatants (nuclear extracts) were collected and stored at 2
80uC until use. Both buffers were supplemented with 0.1 mM
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PMSF and 1 mg/ml CLAP, as well as with 1 mM DTT before use.
Protein concentration of the extracts was measured using the
Bradford assay. Samples were then denatured with 2x concen-
trated denaturing buffer at 95uC for 5 min, and 100 ml of each
sample were used for SDS-PAGE.
SDS-PAGE and Western Blotting
Protein samples were separated by SDS-PAGE in 7.5%
(REST), 8% (NMDAR subunits) or 10% (AMPAR subunits)
polyacrylamide gels, transferred to PVDF membranes (Millipore,
Billerica, MA) and immunoblotted. The membranes were blocked
with Tris-buffered saline-Tween (TBS-T) (in mM: 20 Tris, 137
NaCl, pH 7.6, and 0.1% Tween20) with 5% non-fat milk, for 1 h
at room temperature, and then incubated with the primary
antibody in TBS-T 5% milk, overnight at 4uC. Incubation with
antibodies against a-tubulin (Sigma-Aldrich, #T5168), b-actin
(Sigma-Aldrich, #A5441) and a-spectrin (Millipore, #1622) were
performed for 1 h at room temperature, whereas antibodies
against REST(Millipore, #07-579), GluA1 (Millipore, #AB1504),
GluA2 (Millipore, #MAB397), GluN1 (Millipore, #MAB363),
GluN2A (Millipore, #AB1555P) and GluN2B (BD Biosciences,
San Jose, CA, #610417) were incubated overnight at 4uC. After
extensive washing, membranes were incubated with the secondary
antibody conjugated with alkaline phosphatase for 1 h at room
temperature. After additional washes, the membranes were
developed using the enhanced chemifluorescence (ECF) substrate,
and scanned on the Storm 860 Gel and Blot Imaging System
(Amersham Biosciences, Buckinghamshire, UK). The density of
the bands was analyzed with ImageQuant 5.0 software. For
subsequent reprobing, the membranes were stripped of antibody
with NaOH 0.2 M for 20 minutes, blocked again and incubated
with the appropriate antibodies.
Statistical Analysis
Results are presented as means 6 S.E.M. of the number of
experiments indicated performed in different preparations. The
normality of the data was assessed using the Kolmogorov-Smirvov
test. Statistical significance was assessed by one-way analysis of
variance (ANOVA) followed by the Bonferroni’s or Dunn’s
Multiple Comparison test, or by Student’s t-test (always performed
in pairs by comparing each OGD condition with the respective
control), as indicated in the figure captions. These statistical
analyses were performed using the software package GraphPad
Prism 5.
Results
OGD induces delayed neuronal death in mature
hippocampal neurons
In order to characterize the neuronal injury induced by in vitro
oxygen and glucose deprivation, primary hippocampal neuronal
cultures were subjected to different periods of OGD, followed by
24 h incubation in culture conditioned medium, after which cell
viability was evaluated by analysis of the nuclear morphology.
Periods of OGD$1 h 30 min resulted in a decrease in cell
viability of nearly 20% (Figure 1A). Therefore, in all forthcoming
experiments the cells were subjected to OGD for 2 h and further
incubated in culture conditioned medium for the indicated periods
of time.
To test whether OGD causes delayed neuronal death, we
assessed cell viability at different periods after the insult, by
quantification of the LDH release (Figure 1B). We observed that
at post-incubation periods of up to 18 h after OGD there was no
detectable change in cell viability, whereas at 24 h after the insult
LDH release was increased, thus confirming that the OGD
challenge induces delayed neuronal death, similarly to the
ischemic insult in vivo [5,18–20].
Previous studies have indicated that the intracellular effects of
ischemia include the activation of calpains, a family of calcium-
activated cysteine proteases which trigger substrate-specific prote-
olysis that may contribute to neuronal death [21], after both in vivo
[22,23] and in vitro ischemia [24–26]. Calpain activation (usually
detected as the breakdown products of a preferred substrate,
spectrin) can therefore serve as an indirect indicator of the
induction of cell death. As expected, no significant OGD-induced
calpain activation was observed 7 h (Figure 1C) after subjecting
hippocampal neurons to the ischemic insult (a time point at which
there is still no significant cell death, as assessed by quantification
of LDH release, Figure 1B). However, at 24 h after the insult,
significant activation of these proteases was observed, as indicated
by the formation of the calpain-specific145 kDa spectrin cleavage
product (Figure 1D). No 120 kDa cleavage products were
detected, indicating that caspase-3 does not contribute to spectrin
cleavage under the experimental conditions used [27]. We have
used a calpain inhibitor (MDL 28170) to test whether the OGD-
induced formation of the 145 kDa spectrin cleavage product was
specifically mediated by calpain activation upon OGD (Figure
1D). We observed that in the presence of the calpain inhibitor
there is a dramatic reduction in the formation of the OGD-
induced spectrin cleavage product (145 kDa). Taken together,
these results show that incubation under OGD (2 h) results in
significant cell death in primary hippocampal neurons, 24 h after
the insult. Therefore, this protocol can be used to investigate the
ischemic response at earlier (7 h) or later (24 h) recovery periods
after the insult.
OGD-induced hippocampal neuronal death is prevented
by glutamate receptor antagonists
Glutamate toxicity due to overactivation of glutamate receptors,
or excitotoxicity, has been previously related to cerebral ischemia
and mediates an important component of global ischemia-induced
neuronal damage, given that application of glutamate receptor
antagonists attenuates synaptic transmission and neuronal death,
conferring neuroprotection [28,29]. To analyze the contribution
of NMDA and AMPA ionotropic glutamate receptors to neuronal
death elicited by OGD, hippocampal neuronal cultures were
submitted to OGD in the absence or in the presence of MK801
(selective NMDAR antagonist), GYKI 52466 (selective AMPAR
antagonist) or Naspm (selective Ca2+-permeable (CP) AMPAR
antagonist). All antagonists were added prior to OGD and kept
during the stimulation and post-stimulation periods. Cell viability
was assessed 24 h after the stimulus by analysis of nuclear
morphology (Figure 2A–C) and by quantification of LDH release
(Figure 2D–F). Both assays showed that cell death induced by
OGD was prevented by the NMDA and AMPA receptor
antagonists. Also, the selective CP-AMPARs antagonist Naspm
inhibited the increase in LDH release, indicating the partipation of
this subtype of AMPARs in the neuronal death elicited by OGD.
Taken together, these results confirm that both AMPA and
NMDA receptors are involved in OGD-induced neuronal death
and mediate the main excitotoxic component of this in vitro model
of cerebral ischemia.
OGD induces large-scale regulation of hippocampal gene
expression
To investigate the molecular mechanisms involved in the
neuronal response mediated by the OGD insult, we performed a
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whole-rat genome Agilent microarray analysis. Total RNA from
rat hippocampal neuronal cultures submitted to control conditions
or OGD were analyzed after 7 h and 24 h incubation in culture
conditioned medium, in order to compare gene expression profiles
at a time point prior to and after the onset of cell death. All
experimental conditions were performed with three independent
biological replicates. Student’s t-test was used to determine the
genes whose expression was significantly different between cells
subjected to ischemic injury and the correspondent control. Only
genes with p,0.05 and with an expression fold change of 2.0
relatively to the control condition were considered differentially
expressed and selected for further analyses. From the approxi-
mately 44 000 probes present on each array, the expression levels
of 4 506 transcripts were altered 7 h after OGD, whereas 1 922
transcripts were differently expressed at 24 h after OGD, when
compared to their respective controls (p,0.05, Student’s t-test). Of
these, we observed that at 7 h and 24 h of incubation after OGD,
the levels of a total of 413 and 499 transcripts were more than two
fold altered in response to OGD, respectively (Figure 3A).
Figure 3B–C shows the number of genes that were exclusively
altered at 7 h or 24 h after OGD, as well as the number of genes
affected at both time points. Of all the transcripts up-regulated
after OGD, the expression levels of 333 transcripts were increased
specifically 7 h after injury, 419 transcripts were exclusively
Figure 1. OGD induces delayed neuronal death of mature hippocampal neurons in culture. (A) OGD causes hippocampal neuronal cell
death, as determined by analysis of nuclear morphology. After incubation under OGD conditions for 1 h (n = 3), 1 h30 (n = 12) and 2 h (n = 10), cells
were returned to the 5% CO2 incubator for 24 h. Cell viability was then assessed by analysis of the nuclear morphology. Pyknotic nuclei (arrows) were
counted as dead cells. The results were expressed as the percentage of dead cells relatively to the total cell number. The right panel depicts nuclear
morphology of neurons subjected to control and 2 h OGD. (B) Time-course of OGD-induced neuronal death, as determined by LDH release. Cells
were subjected to OGD for 2 h and the LDH release was assessed 0 h (n = 6), 4 h (n = 5), 7 h (n = 3), 14 h (n = 6), 18 h (n = 6) and 24 h (n = 13) after the
stimulus. (C–D) OGD induces cleavage of spectrin and the formation of spectrin breakdown products (SBDPs). SBDPs protein levels were analyzed by
Western blot 7 h (C) and 24 h (D) after 2 h of OGD. The calpain inhibitor MDL 28170 (50 mM) was added 30 min prior to stimulation and kept during
the stimulation and post-stimulation period (24 h). Actin was used as loading control. Bars represent the mean 6 SEM of five (C) or ten (D)
independent experiments performed in distinct preparations. *p,0.05, ***p,0.001, as determined by the Student’s t-test (C) and One-way ANOVA
followed by Dunn’s Multiple Comparison Test (D; *p,0.05 for the OGD condition compared to control,##p,0.01 for the OGD+MDL28170 condition
compared to OGD).
doi:10.1371/journal.pone.0099958.g001
Figure 2. Inhibition of glutamate receptors protects hippocampal neurons against OGD-induced cell death. Mature hippocampal
neurons were subjected to 2 h OGD in the absence or presence of glutamate receptor antagonists. When present, the antagonists were added
15 min prior to stimulation and kept during the stimulation and post-stimulation periods. Cell viability was assessed 24 h after the stimulus by
analysis of the nuclear morphology (A–C) and by determination of the LDH release (D–F). Bars represent the mean 6 SEM of 4–9 independent
experiments, performed in distinct preparations. Statistical analysis was performed using One-way ANOVA followed by Bonferroni’s Multiple
Comparison Test: *p,0.05, **p,0.01, ***p,0.001, relative to control; #p,0.05, ##p,0.01, ###p,0.001 relative to OGD condition. MK-801, selective
NMDAR antagonist; GYKI 52466, selective AMPAR antagonist; Naspm, selective CP-AMPAR antagonist.
doi:10.1371/journal.pone.0099958.g002
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increased after 24 h after the insult and a total of 80 transcripts
were found to be up-regulated after both time periods of
incubation (Figure 3B). On the other hand, 360 transcripts were
exclusively down-regulated at 7 h after OGD, whereas only 64
transcripts had reduced expression levels specifically at 24 h after
OGD. A total number of 27 transcripts were down-regulated both
at 7 h and 24 h after OGD (Figure 3C). These results indicate
that whereas at 7 h after in vitro ischemia the changes in the
transcriptome are related to both an up- and down-regulation of
gene expression, at 24 h after the insult there is mainly up-
regulation of gene expression.
Transcriptional adaptations induced by OGD
To study the changes induced by the OGD insult in terms of
functional gene groups, we next considered all the transcripts that
displayed a significant expression increase or decrease at 7 h and
24 h of incubation after injury (or at both time points of recovery,
where indicated) by gene ontology categories using the informatics
tool GoMiner. The most up- and down-regulated genes at 7 h,
24 h or at both time points after OGD (i.e., genes that are
regulated as a constitutive response to in vitro ischemia) belong to a
diverse set of categories and are indicated in Tables S2–S4.
Figure 4 shows the number of genes up- or down-regulated at 7 h
and 24 h after OGD for different ontological classes. We found
that genes related with metabolic processes, signaling pathways,
receptor activity, transcription, RNA biosynthesis and apoptosis
were the most altered after OGD. Genes included in other
categories such as ion transmembrane transporter activity,
inflammation and synapse were also highly regulated by the
OGD challenge. Whereas the most up-regulated classes (and the
number of genes with increased expression included in each one)
are similar between 7 h and 24 h of recovery, the pattern of down-
Figure 3. Summary of gene expression changes at 7 h and 24 h after OGD. (A) Student’s t-test analysis was applied to the microarray data
to identify all genes whose expression was significantly different between conditions (p,0.05). Up-regulated and down-regulated genes include
those whose expression levels had a fold change$2.0. (B and C) Number of up-regulated (B) or down-regulated (C) transcripts at 7 h and 24 h after
2 h OGD. The intersection represents the number of transcripts whose transcription was changed in both recovery periods. The transcripts used in
this analysis were considered differentially expressed after using two cut-off criteria: a p-value ,0.05 and a fold change of 2.0. The VENNY informatic
tool was used to compare the lists of transcripts to obtain the Venn Diagrams.
doi:10.1371/journal.pone.0099958.g003
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regulation is different. It is clear that at 7 h after OGD there are
more genes whose expression is decreased than at 24 h, in all the
classes considered (Figure 4).
We then selected the functional gene classes with potential
relevance to the excitotoxic process, comprising a total of 586 and
403 genes that were altered at 7 h and 24 h after OGD,
respectively, and analyzed changes in gene expression among
genes belonging to those classes. In Figure 5 we indicate the
percentage of altered genes in ontology groups regulated
exclusively at 7 h (A), 24 h (B) or regulated at both periods of
recovery (C). The categories of metabolic processes and signaling
pathways contained the largest percentage of regulated (up- or
down-regulated) genes at both periods of incubation after OGD,
both constitutively or time point-specific regulated genes. Addi-
tionally, differential effects were observed when comparing the
expression profiles at 7 h and 24 h after injury. For example, at
24 h there was an increase in the percentage of up-regulated genes
that code for proteins involved in the response to oxidative stress
and receptor activity, whereas fewer genes were up-regulated in
classes such as transcription and RNA synthesis, when compared
to what is observed 7 h after OGD. Also, at 24 h more genes were
down-regulated in classes such as response to oxidative stress and
synapse, whereas genes coding for proteins related with transcrip-
tion, RNA synthesis, metabolism and signaling pathways were less
down-regulated. The complete lists of genes for every ontology
group considered at 7 h, 24 h and both time points used in these
analyses are shown in Tables S5–S7.
Taken together, these results demonstrate that the OGD model
induces similar changes in functional groups of genes that have
been shown to be differently regulated after in vivo ischemia [2–
4,6–9]. Moreover, although many genes were differentially
expressed at both time points of recovery, most genes were
exclusively altered at only one of the post-injury periods tested,
suggesting that specific molecular pathways can be regulated at an
early or late response to OGD.
Genes coding for synaptic proteins are down-regulated
after OGD
To validate the gene expression profiles obtained in the
microarray assay, we performed qPCR analyses for 11 selected
genes that were differentially regulated (up- and down-regulated)
and belong to different functional categories (Table S8). Most of
the genes tested with qPCR analysis showed changes in expression
following OGD in the same direction as determined in the
microarray experiment (Figure S1).
According to the microarray data, genes coding for several
synaptic proteins were differentially regulated after the OGD
challenge (Tables S5–S7, Synapse category). We chose to
validate the gene expression changes obtained in the microarray
assay for 15 distinct synaptic protein genes (Table 1). These genes
are of particular interest since they code for proteins involved in
glutamatergic neurotransmission, whose imbalance contributes to
ischemic injury. Thus, the expression levels of genes encoding
proteins related with AMPAR trafficking (Pick1, Grip1, Cacgn3
and Cacgn8), pre- and post-synaptic compartments (Sypl2,
Snap25, Clstn2, Clstn3, Dlgap2 and Fmr1) and subunits of the
AMPA (Gria1 and Gria2) and NMDA (Grin1, Grin2a and
Grin2b) receptors were analyzed by qPCR (Figure 6). Notably,
most of these genes were down-regulated after the OGD insult, as
indicated by the microarray experiment (Table 1) and confirmed
by qPCR analyses (Figure 6). For instance, the results obtained
for Cacgn3, Clsnt2 and Clstn3 correlated with the microarray
data, since their expression levels were reduced at the same time
points of incubation after OGD as in the microarray assay. Sypl2
was also in agreement with the microarray data, and it was the
only synaptic protein gene confirmed to be up-regulated in
response to the OGD insult; the up-regulation of Frm1 7 h after
OGD indicated in the microarray data was not confirmed by
qPCR. In some cases, qPCR analysis allowed the detection of a
decrease in the mRNA levels of genes at earlier (Gria1 and
Grin2a), later (Pick1, Snap25 and Dlgap2) or at both (Grip1,
Grin1 and Grin2b) time points of incubation after OGD rather
than just the one indicated in the microarray data. The down-
regulation of Cacgn8, as indicated by the microarray data, was not
detected by qPCR analysis, whereas Gria2 was found to have
reduced mRNA levels at 24 h after the insult, which was
undetected in the microarray experiment.
In general, the qPCR analysis confirmed the OGD-induced
changes in the expression levels of synaptic protein genes detected
with the microarray data analysis. As such, our results show that
OGD activates a transcriptional program leading to the repression
of genes related with the synaptic function in hippocampal
neurons, suggesting that changes at the synapse take place after the
ischemic event.
The expression levels of the silencing transcription factor
REST increase after OGD
The gene-silencing transcription factor REST (repressor
element-1 silencing transcription factor) actively represses neuro-
nal genes important for synaptic plasticity and remodeling, such as
synaptic vesicle proteins, synaptic structural proteins and recep-
tors, in progenitor and non-neuronal cells [30–32]. As neuronal
differentiation takes place, REST is down-regulated, an essential
process for the maintenance of the neuronal phenotype. Neuronal
insults, such as transient global cerebral ischemia, activate REST
in CA1 hippocampal neurons destined to die [20,33,34]. We
therefore tested whether the OGD insult also triggers the
induction of REST. In the microarray data the expression fold
change for Rest was 1.63 at 7 h after OGD (p=0.016). We also
analyzed Rest mRNA expression in hippocampal cultures
submitted to OGD by qPCR, and observed that even though at
7 h after the insult the mRNA levels of REST were not
significantly different from the control, a significant increase was
observed at 24 h (Figure 7A). Consistently, the increase in the
mRNA levels of Rest translated in the induction of the REST
protein levels at the same time-point after OGD (Figure 7B).
These results corroborate previous observations suggesting that
REST may be one of the transcriptional factors mediating the
transcriptional response to ischemia. Indeed, 9 out of the 15 genes
encoding synaptic proteins that were down-regulated after OGD
contain putative REST-binding sites (Figure 7C, according to
[35]) and may therefore be regulated by REST.
We next analyzed whether genes that have previously been
described to have REST enrichment at their promoters after
transient global brain ischemia in rats [33] were differently
expressed after OGD (Figure 7D). Interestingly, analysis of the
microarray data showed that several genes with enriched REST
[33] have decreased expression levels at 7 h or 24 h of recovery
Figure 4. Time course analysis of OGD-induced differential gene expression within each functional gene category. The number of
genes that were up-regulated (black bars) or down-regulated (white bars) at each period of recovery after the OGD insult is plotted for each
functional gene category. Gene ontology analyses were performed using GoMiner and functional groups were selected manually.
doi:10.1371/journal.pone.0099958.g004
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after OGD; in the case of Snap25, Grin1, Grin2a and Grin2b, the
down-regulation in their mRNAs was further confirmed by qPCR
analysis in the present work (Figure 6). Gria2, the gene encoding
GluA2, has been proven to be a REST target gene in the post-
ischemic CA1 hippocampal region [20,33,34]. Although our
microarray analysis did not detect significant differences in GluA2
expression, qPCR analysis showed down-regulation of GluA2
mRNA levels 24 h after OGD (Figure 6C). Collectively, these
observations support previous evidence for the hypothesis that
REST is activated under ischemic conditions [20,33,34]. As such,
REST activation may be responsible for the repression in the
transcription of some of the synaptic protein genes that we
observed to be down-regulated under OGD.
OGD down-regulates total and cell surface GluA1 protein
levels
Previous studies indicate that both transient global cerebral
ischemia and in vitro ischemic insults can down-regulate the
AMPAR subunit GluA2, both at the mRNA and protein levels, in
hippocampal neurons [11,12,20,33,36–39], thus inducing a switch
from GluA2-containing/Ca2+-impermeable AMPARs to GluA2-
lacking/Ca2+-permeable AMPARs. However, according to our
qPCR data, the mRNA levels of both GluA1 (Gria1) and GluA2
(Gria2) subunits were decreased after the OGD insult (Figure
6C). We therefore tested whether total protein levels of GluA1 and
GluA2 varied in the same direction as their respective mRNAs, at
7 h and 24 h after OGD. Despite the reduction in the mRNA
levels of GluA1 observed after 7 h after injury, the decrease in the
protein levels was detected only 24 h after OGD. Curiously,
GluA2 protein levels remained unaltered after OGD, in spite of
the reduction in its mRNA levels detected by qPCR at 24 h after
the insult (Figure 8A).
We then biotinylated cell surface proteins in hippocampal
neuronal cultures 24 h after incubation under control or OGD
conditions, and purified biotinylated proteins by affinity chroma-
tography to analyze the cell surface content of both subunits of
AMPAR (Figure 8B). We observed that, consistent with the
results obtained for the total protein levels, surface GluA1 was
Figure 5. Ontology of genes differentially expressed at 7 h and 24 h of incubation after 2 h of OGD. Gene ontology analyses included
genes that had a p-value ,0.05 and a fold change of 2.0 and were performed using GoMiner. Classes were selected manually and the number of
genes for each class divided by the sum of the total number of genes in the selected classes (586 genes at 7 h and 403 genes at 24 h). Note that
some genes are included in more than one class. (A) Ontology of genes up-regulated (upper) and down-regulated (lower) relatively to the control at
7 h of incubation in culture conditioned medium after 2 h OGD. In this analysis, the total numbers of up-regulated and down-regulated genes were
232 and 354, respectively. (B) Ontology of genes up-regulated (upper) and down-regulated (lower) relatively to the control at 24 h of incubation in
culture conditioned medium after 2 h OGD. In this analysis, the total numbers of up-regulated and down-regulated genes were 333 and 70,
respectively. (C) Ontology of genes up-regulated (upper) and down-regulated (lower) at 7 h and 24 h of incubation in culture conditioned medium
after 2 h OGD. In this analysis, the total numbers of up-regulated and down-regulated genes were 60 and 31, respectively.
doi:10.1371/journal.pone.0099958.g005
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reduced 24 h after OGD, whereas surface GluA2 expression was
unaffected. These results show that AMPARs present at the cell
surface in a mixed population of hippocampal neurons subjected
to OGD have a decreased content on GluA1 when evaluated 24 h
after the insult, resulting from a delayed reduction in the mRNA
levels of GluA1 in these experimental conditions. The reduction in
AMPAR GluA1 content that we detected may represent a
neuroprotective mechanism occurring in specific neuronal sub-
types in the preparation.
OGD down-regulates GluN2 subunits and increases the
expression levels of GluN3A
The NMDA subtype of ionotropic glutamate receptors has been
extensively studied in ischemic conditions due to their over-
activation by glutamate and subsequent contribution to the
activation of pathologic molecular pathways [29,40]. In the in
vitro ischemia model used in the present work, cell death is also
dependent on the activation of NMDA receptors (Figure 2A, D).
According to our qPCR data, the mRNA levels of GluN1 (Grin1)
and GluN2B (Grin2b) were down-regulated both at 7 h and 24 h
of incubation after OGD, whereas GluN2A (Grin2a) was down-
regulated only at 7 h after the ischemic injury (Figure 6C). We
then analyzed the total protein levels of these subunits by Western
blot (Figure 9A). At 24 h after OGD, protein levels for both
GluN2A and GluN2B were decreased, whereas GluN1 was not
significantly changed, despite a clear tendency for increased
expression. Together, these results indicate that OGD leads to the
down-regulation of the most abundant GluN2 subunits in the
hippocampus, thereby influencing the subunit composition of
NMDARs.
Given that the total protein levels of GluN1 failed to accompany
the decrease on protein levels found for both GluN2A and
GluN2B subunits, we hypothesized that OGD may influence the
expression levels of the GluN3 subunit, which can also promote
GluN1 trafficking to the cell surface [41,42]. In fact, analysis of the
mRNA levels of the GluN3 subunit revealed that GluN3A
displayed a remarkable increase in the mRNA expression 24 h
after OGD, whereas GluN3B mRNA levels remained unaltered at
both periods of recovery (Figure 9B). This suggests that OGD
specifically induces the expression of GluN3A, but not GluN3B,
thus promoting the presence of GluN1-GluN3A receptors in
neurons submitted to ischemic insults. This result is in accordance
with recent observations indicating that GluN3A can be up-
regulated in response to ischemic insults and might therefore exert
a neuroprotective effect against neuronal damage [43].
Discussion
Transient global cerebral ischemia induces a profound change
in the transcriptome of brain cells, which is partially associated
with the induction or repression of specific genes that influence the
outcome of the ischemic insult. However, the mechanisms
responsible for the selective vulnerability of hippocampal neurons
to global ischemia remain to be clarified. As such, in this study we
have subjected mature primary cultures of hippocampal neurons
to OGD, a well-established in vitro model for global ischemia, in
order to identify molecular changes that may be involved in the
response of hippocampal neurons to an ischemic insult. The OGD
challenge induced delayed neuronal death in hippocampal
cultures and activated an excitotoxic component mediated by
NMDA and AMPA receptors as observed in previous studies
[11,12,25,44]. OGD also induced the activation of calpains, which
Table 1. Microarray data showing the effect of OGD in the mRNA levels of genes encoding synaptic proteins.
Gene Gene Name Protein Status Fold Change
AMPAR trafficking Pick1 Protein interacting with PRKCA 1 PICK1 Down-regulated at 7 h 0.48
Grip1 Glutamate receptor interacting protein 1 GRIP1 Down-regulated at 7 h
and 24 h
0.62 (7 h)/0.64 (24 h)
Cacng3 Calcium channel, voltage-dependent,
gamma subunit 3
TARP c3 Down-regulated at 7 h 0.41
Cacng8 Calcium channel, voltage-dependent,
gamma subunit 8
TARP c8 Down-regulated at 24 h 0.64
Pre- and post-synaptic
compartment
Sypl2 Synaptophysin-like 2 SYPL2 Up-regulated at 7 h
and 24 h
2.61 (7 h)/2.63 (24 h)
Snap25 Synaptosomal-associated protein 25 SNAP-25 Down-regulated at 7 h 0.43
Clstn2 Calsyntenin 2 Calsyntenin 2 Down-regulated at 24 h 0.44
Clstn3 Calsyntenin 3 Calsyntenin 3 Down-regulated at 7 h
and 24 h
0.44 (7 h)/0.38 (24 h)
Dlgap2 Discs, large (Drosophila)
homolog-associated protein 2
SAPAP2 Down-regulated at 7 h
and 24 h
0.48 (7 h)/0.4 (24 h)
Fmr1 Fragile X mental retardation 1 FMRP Up-regulated at 7 h 2.34
AMPAR subunits Gria1 Glutamate receptor, ionotropic, AMPA 1 GluA1 Down-regulated at 24 h 0.55
Gria2 Glutamate receptor, ionotropic, AMPA 2 GluA2 No change —
NMDAR subunits Grin1 Glutamate receptor, ionotropic,
N-methyl-D-aspartate 1
GluN1 Down-regulated at 24 h 0.39
Grin2a Glutamate receptor, ionotropic,
N-methyl-D-aspartate 2A
GluN2A Down-regulated at 24 h 0.44
Grin2b Glutamate receptor, ionotropic,
N-methyl-D-aspartate 2B
GluN2B Down-regulated at 24 h 0.44
doi:10.1371/journal.pone.0099958.t001
Ischemia Down-Regulates Synaptic Proteins in Hippocampal Neurons
PLOS ONE | www.plosone.org 11 June 2014 | Volume 9 | Issue 6 | e99958
Ischemia Down-Regulates Synaptic Proteins in Hippocampal Neurons
PLOS ONE | www.plosone.org 12 June 2014 | Volume 9 | Issue 6 | e99958
corroborates previous studies showing that these proteases can
play an important role in the enhancement of cell death induced
by in vitro ischemic insults [24–26].
Although the OGD model has been used to infer about changes
in gene expression associated with pre- and post-conditioning-
derived neuroprotection [45,46], to the best of our knowledge no
similar large scale study was developed so far using this insult as a
tool to study ischemia-induced changes in the transcriptome of
hippocampal neurons at different periods of recovery. Our analysis
has allowed the detection of a large number of altered genes
related with the specific response of neurons to the ischemic insult.
The validity of our approach was confirmed by performing qPCR
analysis of many selected genes belonging to different functional
groups, including the synapse, which was in good agreement with
the microarray data.
At an early time point (7 h) after OGD there are more
differentially regulated transcripts than at 24 h, which corrobo-
rates the notion that the response to ischemia is a dynamic and
coordinated process that starts soon after the insult, but is
extended until later time points. In fact, this is supported by the
observation that genes related with functions such as transcription
and RNA biosynthesis are highly regulated at both periods of
recovery. We also noted that the response at 7 h after OGD is
more associated with a general repression of genes than at 24 h, at
which point there is a general induction of gene expression. This
observation further supports the idea that the response to ischemia
at a delayed time point is still part of an active process that rather
involves the induction than the repression of genes, and excludes
the possibility that an unspecific down-regulation of genes could be
associated with an increased rate of cell death.
Consistent with the results obtained using gene ontology
analysis after in vivo ischemia [2–4,6–9], we found that genes
related with metabolic processes, signaling pathways, receptor
activity, transcription, inflammation, neurotransmitter/glutamate
secretion, RNA biosynthesis and apoptosis were differentially
regulated after OGD. These categories were chosen due to their
relevance in identifying the molecular pathways involved in the
selective vulnerability of hippocampal neurons to ischemic insults.
According to our microarray and qPCR data, most of the synaptic
protein genes considered in this work showed down-regulation
during the recovery periods after the OGD insult. As far as we
know, this is the first study to detect changes in the expression
levels of an extensive group of genes coding for synaptic protein
genes upon ischemia. Down-regulation of some synaptic protein
genes (such as Snap 25, Gria 1,2, and Grin1, 2a) has been reported
previously in studies regarding changes in gene expression after
focal [6] and global [2] ischemia, but the other synaptic protein
genes that we identified had not been previously reported to be
altered after ischemic insults.
Although cerebral ischemia can induce a reduction of spines
and synapses as neurons degenerate [13,47], the down-regulation
of specific synaptic protein genes suggests the initiation of an
adaptive response to hyperexcitability in post-ischemic neurons.
The group of genes involved in synaptic function that we identified
code for proteins that can be involved in many regulatory
processes, i.e. the cycling of synaptic vesicles and neurotransmitter
release at nerve terminals (Snap25), trafficking and stabilization of
glutamate receptors at the cell surface (Pick1, Grip1, Cacgn3 and
8) and propagation of neuronal signal impulses upon cell
stimulation (AMPAR and NMDAR subunits).
SNAP-25 (synaptosomal-associated protein, 25 kDa) is involved
in synaptic vesicle membrane docking and fusion mediated by
SNAREs, therefore contributing to the regulation of neurotrans-
mitter release in presynaptic terminals. Moreover, SNAP-25 has
been shown to have a critical role in PKC-induced, SNARE-
dependent insertion of NMDAR at synaptic sites, a mechanism
relevant to synaptic plasticity [48]. A decrease in the mRNA levels
of SNAP-25 at a later time point after the ischemic insult, as our
data shows, might consist of a protective strategy of neurons to
reduce neuronal hyperexcitability by reducing the release of
glutamate as well as the insertion of NMDAR at the plasma
membrane. PICK1 (protein interacting with C kinase) and GRIP1
(glutamate receptor interacting protein) are both involved in the
trafficking of AMPAR [49]. Under physiologic conditions PICK1
binds to AMPAR subunits GluA2, an interaction known to be
required for AMPAR internalization [50]. In hippocampal
neurons subjected to OGD, rapid PICK1-mediated GluA2
internalization during the OGD insult was found to contribute
to cell death mediated by GluA2-lacking Ca2+-permeable
AMPARs [12]. A delayed decrease in the levels of PICK1
following the reduction in its mRNA levels would probably
account for the maintenance of the GluA2 subunit at the cell
surface of post-ischemic neurons, as observed in our work.
Interestingly, the gene coding for TARPc3 was also shown to be
down-regulated after OGD, suggesting another mechanism
through which trafficking of AMPARs to the cell surface is
changed after ischemia. Moreover, it has been shown that genetic
deletion of TARPc8 selectively abolishes sustained depolarizations
in hippocampus mediated by kainate activation of AMPA
receptors [51]. Therefore, it would be interesting to confirm
whether the protein levels of TARPc3 or TARPc8 follow the same
pattern of their respective mRNAs and, if so, their implication for
the transport of AMPARs in ischemia. FMRP (Fragile X mental
retardation protein) is a dendritic modulator of mRNA transport
and translation repression, and knock-out mice present reduced
levels of many postsynaptic proteins [52]. SAPAP2 (Synapse-
associated protein 90/postsynaptic density-95-associated proteins,
encoded by Dlgap2) is a member of the SAPAP family of
postsynaptic proteins that can interact with various synaptic
components, including the NMDARs [53–55]. Since both the
genes encoding for FMR1 and SAPAP2 were down-regulated after
OGD, a decrease in the respective proteins could hypothetically
play a role in the re-organization of functional multiprotein units
at post-ischemic synapses. Additionally, calsyntenin-3 (Clsnt3),
which is dramatically reduced after OGD, has been recently
attributed a function in promoting synapse development, with
Clstn32/2 mice showing compromised inhibitory and excitatory
neurotransmission [56]. Overall, our results suggest that neurons
can activate a program to decrease the expression of genes coding
for proteins involved in the machinery of synaptic transmission,
which might contribute to reduce glutamate-mediated signaling
and excitotoxicity.
Figure 6. OGD induces changes in the mRNA levels of transcripts encoding synaptic proteins. Total RNA was extracted with TriZol 7 h
and 24 h after the OGD insult. Quantitative PCR analysis was performed using cDNA prepared from 1 mg of total RNA and specific primers for each
selected gene. Fold change in mRNA levels was normalized to Gapdh and Actb. Quantitative PCR analysis showed that genes encoding proteins
associated with AMPAR trafficking (A) and pre- and post-synaptic compartments (B), as well as subunits of the AMPA and NMDA receptors (C) were
mostly down-regulated (with the exception of Sypl2, which had increased expression levels) after OGD, at least at one of the time points analyzed
after OGD. Bars represent the mean 6 SEM of 5 independent experiments, performed in distinct preparations. *p,0.05, **p,0.01, ***p,0.001, as
determined by the Student’s t-test on log-transformed data.
doi:10.1371/journal.pone.0099958.g006
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We also obtained evidence that the transcription factor REST is
induced upon an OGD insult to cultured hippocampal neurons, in
agreement with previous studies showing an increase of REST
mRNA in the CA1 region of the hippocampus [20,33].
Noteworthy, knockdown of REST protected CA1 neurons from
OGD-induced death, thus suggesting that expression of REST is
causally related with neuronal death [20,34,57]. One of the most
studied targets of REST repressive activity is the AMPAR subunit
GluA2, to whose promoter REST can bind, thus suppressing
GluA2 expression [20,32–34]. The increase in REST levels
promoted by ischemic insults has also been shown to correlate with
the down-regulation of the Na+-Ca2+ exchanger 1 (NCX1) [57].
However, there is also evidence pointing to a neuroprotective role
of REST in some circumstances. Formisano and co-workers
showed the REST-mediated repression of the expression of the
opioid receptor 1 in interneurons, under ischemia conditions, was
neuroprotective [59]. Recent evidence suggests that REST can
have a crucial role in mediating neuroprotection in the ageing
brain [58]. Indeed, this study shows that whereas in healthy ageing
neurons REST is significantly up-regulated and represses many
genes associated with cell death pathways, nuclear REST
expression is substantially reduced in patients with age-related
neurodegenerative diseases such as Alzheimer’s disease. In these
neurons, reduced REST binding leads to increased expression of
many genes related with Alzheimer’s disease pathology. The
repression of cell death-associated genes therefore suggests that
REST might be neuroprotective [58].
Other genes have been identified with REST-occupied target
sequences (RE1 sites) after a genome-wide approach using serial
analysis of chromatin occupancy in HEK cells [35], among which
are some of the synaptic protein-encoding genes analyzed in the
present work (Figure 7C). Interestingly, we found that several
genes previously described to have REST enrichment at their
promoters after in vivo ischemia [33] have reduced mRNA levels
after the OGD insult (Figure 7D), thus providing a new list of
REST targets with a potential role in ischemia, and further
supporting the role of REST as a repressive transcription factor
under ischemic conditions. Indeed, our observations are supported
by other studies showing REST enrichment at the promoters of
Grin1, Grin2a, Grin2b and Snap25 [33], as well as by two recent
reports confirming the regulation of Grin2a and Snap25 by REST
[58], and identifying Gria1, Gria2 and Grin1 as REST targets
Figure 7. OGD increases REST expression in mature hippocampal neurons. (A) Quantitative PCR analysis showed the OGD insult induced a
marked increase in Nrse (Rest) mRNA. Total RNA was extracted with TriZol 7 h and 24 h after the OGD insult. Quantitative PCR analysis was performed
using cDNA prepared from 1 mg of total RNA and specific primers for each selected gene. Fold change in mRNA levels was normalized to Gapdh and
Actb. Bars represent the mean 6 SEM of three independent experiments, performed in distinct preparations. *Significantly different from control
(*p,0.05, Student’s t-test on log-transformed data). (B) Representative Western blot shows a marked increase in REST protein levels, both in the
cytoplasmic and nuclear fractions of hippocampal neurons submitted to OGD followed by 24 h of incubation in culture conditioned medium (n= 3).
Actin was used as loading control. (C) Putative RE-1 sequence(s)/REST-binding site(s) in synaptic genes (according to [35]) found to be down-
regulated after OGD. (D) Genes with enrichment of REST after ischemia (according to [33]) found to be differently expressed after OGD.
doi:10.1371/journal.pone.0099958.g007
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[60]. Overall, these studies confirm the binding of REST to the
promoter of some of the synaptic protein genes that we found to be
down-regulated after OGD and which contain a putative REST
binding site. Of note, our study proposes novel REST targets, such
as the SAPAP2, Calsyntenin 2, Synaptophysin-like 2, TARPc3
and GRIP1 genes. Since several of the synaptic protein genes we
found to be down-regulated have putative REST-binding sites, it
will be of interest to confirm whether REST can indeed bind to
the promoter of these genes under ischemic conditions.
Interestingly, ischemia-induced changes in the protein levels of
synaptic components suggest that important alterations occur at
the synapses of post-ischemic neurons. In particular, our results
support the hypothesis that transcription-dependent mechanisms
take place in insulted neurons that promote the reduction of
neuronal activity through down-regulation of the expression of
central synaptic players. In particular, given that NMDARs and
AMPARs have been long considered important targets for
therapeutical intervention, information concerning their post-
ischemic expression levels is of the upmost interest.
Our results indicate that at 24 h after a 2 h OGD insult,
AMPARs present at the cell surface of cultured hippocampal
neurons have a decreased content of GluA1 subunits, whereas
GluA2 protein levels were unchanged. Previous studies using
cultured hippocampal neurons and the OGD stimulus showed
early effects at the level of AMPAR traffic. Brief OGD caused the
internalization of synaptic GluA2-containing AMPAR in hippo-
campal neurons [11,12]. Other studies indicated that global
ischemia triggers the reduction of GluA2 expression in the
hippocampus CA1 region neurons, both at the mRNA [36,39]
and protein levels [37,38], resulting in increased levels of Ca2+-
permeable AMPA receptors. In the present study, the antagonist
for Ca2+-permeable AMPAR, Naspm, protected hippocampal
neurons from OGD-induced cell death (Figure 2F), supporting,
along with other studies (e.g. [37]), a function for Ca2+-permeable
AMPAR in ischemia-induced cell death. However, in cultured
hippocampal neurons we failed to detect changes in GluA2
expression and traffic reported by others, presumably because
these changes are cell-type specific and become diluted in a mixed
population of hippocampal neurons. Also, the intensity of the
ischemic insult might influence transcriptional and post-transcrip-
tional regulatory mechanisms which may explain different results
obtained in distinct works. Nevertheless, our study has shown for
the first time a dramatic decrease in the total mRNA and protein
levels of GluA1 24 h after a 2 h OGD insult. The decreased levels
of GluA1-containing AMPARs likely result in a depression of
synaptic transmission, with consequences similar to the increased
internalization of AMPARs found in CA3 pyramidal neurons
following a 15 min OGD protocol [61]. Both the endocytosis of
AMPAR [61] and the delayed decrease on GluA1 expression after
OGD that we describe here are potentially neuroprotective
mechanisms.
Figure 8. Ischemic insults affect the protein levels of the AMPAR subunits GluA1 and GluA2. (A) Total protein extracts were prepared 7 h
and 24 h after the OGD insult and Western blot analysis were performed. Total GluA1 is decreased after 24 h, whereas GluA2 levels remain unaltered
following both periods of recovery. The left panel shows a representative Western blot for total GluA1 and GluA2 present in cell lysates after OGD.
The right panel represents the quantification of the Western blots. Bars represent the mean 6 SEM of five independent experiments, performed in
ditinct preparations. (B) GluA1 and GluA2 surface levels were analyzed after biotinylation of cultured hippocampal neurons, 24 h after the OGD insult.
At this time point after OGD GluA1 is removed from the surface, whereas GluA2 surface levels remain unaltered. The left panel shows a representative
Western blot for surface GluA1 and GluA2 after the insult. Total actin (from the total extract) was used as loading control. Bars represent the mean 6
SEM of 3–4 independent experiments, performed in distinct preparations. *p,0.05, as determined by the Student’s t-test.
doi:10.1371/journal.pone.0099958.g008
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Furthermore, we found that the subunit composition of
NMDARs is altered after the OGD insult, which is in agreement
with previous studies showing a down-regulation of genes
encoding for subunits of the NMDARs after in vivo [6,62–64]
and in vitro [13,65] ischemia. In our experimental system, OGD
decreased the total mRNA and protein levels of the GluN2
subunits without affecting the protein levels of the GluN1 subunit
(Figure 9). Additionally, we investigated the role of GluN3
subunit (GluN3A and GluN3B) expression in hippocampal
neurons submitted to OGD since the GluN3 subunits are now
recognized players in the modulation of NMDAR activity [66].
Interestingly, GluN3A expression is induced by OGD (Figure
9B), corroborating the results obtained in a recent study showing
that GluN3A protein levels increase in neurons submitted to OGD
and focal ischemia [43], but in disagreement with an earlier report
showing that focal ischemia down-regulates GluN3A at the
Figure 9. OGD affects the expression levels of NMDAR subunits. (A) Total protein extracts were collected 7 h and 24 h after OGD and
Western blot analysis was performed. Whereas total GluN1 levels tend to increase after the insult, a decrease in total GluN2A was observed after both
periods of recovery while GluN2B decreased at 24 h after the OGD insult. The left panel shows a representative western blot for GluN1, GluN2A and
GluN2B levels after OGD. The right panel represents the quantification of the Western blots. Actin was used as loading control. Bars represent the
mean 6 SEM of 5–9 independent experiments, performed in distinct preparations. (B) OGD induces a marked increase in the mRNA levels of GluN3A
but not in GluN3B. Bars represent the mean 6 SEM of 3–5 independent experiments, performed in distinct preparations. *p,0.05, as determined by
the Student’s t-test.
doi:10.1371/journal.pone.0099958.g009
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mRNA and protein levels 24 h after the insult [67]. Although
GluN3 subunits can be found in many brain tissues including the
hippocampus [68,69], the expression of these subunits is tempo-
rally restricted. Whereas GluN3A is predominantly expressed
during early development and diminishes to lower levels in
adulthood, GluN3B levels are low during early development and
gradually increase into adulthood [70]. Compared with NMDARs
comprised of GluN1/GluN2 subunits, GluN3-containing
NMDARs exhibit several different properties, including lower
amplitude currents, lower calcium permeability and reduced Mg2+
sensitivity [70–76]. As such, GluN3 subunits are considered to
have a dominant-negative effect upon NMDAR activity, which
can be an advantage under pathologic conditions. Indeed, the
neuroprotective role of GluN3A against excitotoxicity and
ischemia-mediated injury has been already shown [43,77].
Cultured neurons from GluN3A knock-out mice display greater
vulnerability to toxic NMDA application, whereas neurons
expressing transgenic GluN3A are more resistant to NMDA-
mediated neurotoxicity and focal ischemia than wild-type neurons
[77]. Although some evidence suggests that the protective role of
GluN3A is associated with a decrease in Ca2+ permeability and in
the production of ROS mediated by NMDARs [43], further
studies are required to confirm the up-regulation of GluN1/
GluN3A receptors upon ischemic insults and to understand the
role mediated by these receptors in post-ischemic neurons.
Importantly, as no significant changes were observed for the
GluN3B subunit, neither at the mRNA (the present study) or
protein [43] levels after ischemic insults, it is probable that this
subunit is not involved in the pathological response mediated by
ischemia, at least in hippocampal neurons.
Conclusions
The present study shows that the OGD model not only mimics
cell death events induced by cerebral ischemia, but can also serve,
when combined with the microarray technology, as a useful tool to
gain insight into particular cellular and molecular mechanisms
evoked by global ischemia in hippocampal neurons. Notably, our
results suggest that OGD induces the activation of a transcrip-
tional program that represses the expression of many synaptic
protein genes that encode for proteins mainly associated with
glutamatergic neurotransmission. In particular, we have shown
that OGD alters the expression of AMPA and NMDA receptor
subunits that modulate the ion channel activity of the receptors,
namely Ca2+-permeability. Given that NMDA and AMPA
receptors have long been considered important targets for
therapeutical intervention, information concerning the post-
ischemic expression levels of these receptor subunits is crucial to
guarantee efficacy of potential neuroprotective strategies concern-
ing the activation and further downstream signaling mediated by
these receptors.
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